# FDA Inspection 1092472 - Aprecia Pharmaceuticals LLC - May 23, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/aprecia-pharmaceuticals-llc/657e2cf7-1a69-4e18-a8f7-a3f202d445a0
Source feed: FDA_Inspections

> FDA Inspection 1092472 for Aprecia Pharmaceuticals LLC on May 23, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1092472
- Company Name: Aprecia Pharmaceuticals LLC
- Inspection Date: 2019-05-23
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1264269 - 2025-03-21](https://www.globalkeysolutions.net/records/fda_inspections/aprecia-pharmaceuticals-llc/47a24c0c-b6f4-4239-a0a2-56c8eeb394e0)
- [FDA Inspection 1054779 - 2018-05-23](https://www.globalkeysolutions.net/records/fda_inspections/aprecia-pharmaceuticals-llc/422d9046-0c0e-47e2-b156-1fe042ad6213)

Company: https://www.globalkeysolutions.net/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
